Skip to content
DraconiticResearch
Search Sources API
194,164 studies31 sourcesUpdated 46 min ago
PreprintCC BY-NC-NDbioRxiv

A minimal two-residue C-terminal truncation of AID in adult-onset hyper-IgM syndrome type 2 (HIGM2)

  1. 1Aarhus University

Abstract

Activation-induced cytidine deaminase (AID), encoded by AICDA, facilitates class-switch recombination (CSR) and somatic hypermutation (SHM) in activated B cells. Loss of AID function causes hyper-IgM syndrome type 2 (HIGM2). While typically autosomal recessive, three C-terminal truncation variants have been reported to act in autosomal dominant manner. We describe a novel heterozygous AICDA nonsense variant, c.589G>T (p.G197*), that truncates the final two C-terminal residues of AID and results in adult-onset HIGM2. Single-cell sequencing of primary patient B cells revealed a complete block in CSR and a [~]10-fold reduction in SHM. AICDA mRNA expression was balanced between wild-type and variant alleles, yet AID protein abundance was reduced to [~]56% with normal subcellular localization. Remarkably, inducible germinal center (iGB) cultures restored CSR in purified naive patient B cells. CRISPR-Cas9 editing of healthy donor B cells confirmed that the iGB platform can rescue B cells harboring heterozygous, but not homozygous, AICDA variants. These results demonstrate that even a two-amino-acid truncation at the AID C-terminus is sufficient to disrupt its function and cause HIGM2.

Related

  1. N-terminal truncation diversifies USP18 function during early myogenesis
    V. Raz, T. Nijssen, S. Draganov +5
    bioRxivPreprintCC BYFull textCell biologybioRxiv
  2. Abnormal nuclear organization impairs adipogenic lineage commitment and terminal maturation in Hutchinson-Gilford progeria syndrome (HGPS)
    N. Gogia, A. Rodriguez Gonzalez, L. Eisenklam +2
    bioRxivPreprintAll rights reservedFull textCell biologybioRxiv
  3. Hyperphagia is prominent in adult patients with short bowel syndrome: A role for the colon?
    Salma Fourati, Brune de Dreuille, Joanna Bettolo +5
    Clinical NutritionPeer-reviewedLicence not statedFull text15 citedGeneral biologyHAL
  4. Latent autoimmune diabetes in an adult patient presenting as suspected neuroendocrine tumour, Crohn's disease and malabsorption syndrome: A case report.
    Ami Bhalodia, Prachi Patel, Rand Daoud +3
    Medicine internationalPeer-reviewedCC BYFull textGenetics & genomicsEurope PMC
  5. Delayed Diagnosis of 48, XXYY Syndrome in an Adult Male Presenting with Severe Insulin Resistance and Hypergonadotropic Hypogonadism: A Case Report
    Buddha Sai Krishna, K Arun, V Jayakaran +2
    Journal of Clinical and Diagnostic ResearchPeer-reviewedCC BY-NC-NDFull textGenetics & genomicsDOAJ
BibTeX
@misc{green2026minimal,
  title = {{A minimal two-residue C-terminal truncation of AID in adult-onset hyper-IgM syndrome type 2 (HIGM2)}},
  author = {K. Green and A. B. Rovsing and E. Terczynska-Dyla and L. Jensen and K. Machalica and J. H. Wolff and L. Westerberg and C. S. Larsen and L. Lin and J. G. Mikkelsen and J. M. B. Jensen and S. E. Degn},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.27.762264},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.27.762264v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - A minimal two-residue C-terminal truncation of AID in adult-onset hyper-IgM syndrome type 2 (HIGM2)
AU  - K. Green
AU  - A. B. Rovsing
AU  - E. Terczynska-Dyla
AU  - L. Jensen
AU  - K. Machalica
AU  - J. H. Wolff
AU  - L. Westerberg
AU  - C. S. Larsen
AU  - L. Lin
AU  - J. G. Mikkelsen
AU  - J. M. B. Jensen
AU  - S. E. Degn
PY  - 2026
DA  - 2026/10/27
PB  - bioRxiv
DO  - 10.64898/2026.10.27.762264
UR  - https://www.biorxiv.org/content/10.64898/2026.10.27.762264v1
AB  - Activation-induced cytidine deaminase (AID), encoded by AICDA, facilitates class-switch recombination (CSR) and somatic hypermutation (SHM) in activated B cells. Loss of AID function causes hyper-IgM syndrome type 2 (HIGM2). While typically autosomal recessive, three C-terminal truncation variants have been reported to act in autosomal dominant manner. We describe a novel heterozygous AICDA nonsense variant, c.589G>T (p.G197*), that truncates the final two C-terminal residues of AID and results in adult-onset HIGM2. Single-cell sequencing of primary patient B cells revealed a complete block in CSR and a [~]10-fold reduction in SHM. AICDA mRNA expression was balanced between wild-type and variant alleles, yet AID protein abundance was reduced to [~]56% with normal subcellular localization. Remarkably, inducible germinal center (iGB) cultures restored CSR in purified naive patient B cells. CRISPR-Cas9 editing of healthy donor B cells confirmed that the iGB platform can rescue B cells harboring heterozygous, but not homozygous, AICDA variants. These results demonstrate that even a two-amino-acid truncation at the AID C-terminus is sufficient to disrupt its function and cause HIGM2.
ER  -